Frost & Sullivan Presents CorMatrix Cardiovascular Inc. with 2008 Healthcare Innovation Award for the Treatment of Cardiovascul...(repairwound management and orthopedic ap...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Frost & Sullivan Presents CorMatrix Cardiovascular Inc. with 2008 Healthcare Innovation Award for the Treatment of Cardiovascular Disease
Date:11/13/2008
repair, wound management and orthopedic applications. Since the launch of CorMatrix's ECM for Pericardial Closure, the technology has been used at more than 220 hospitals across the U.S. and has been implanted in more than 9,000 cardiac procedures.
About CorMatrix ECM Technology(TM)
CorMatrix Cardiovascular holds an exclusive license from Purdue University to research, develop, manufacture and market naturally occurring ECM products for cardiovascular applications. The company currently has U.S. clearance and European approval with a CE Mark to market its ECM Technology as an implant for pericardial closure, clearance in the U.S. for cardiac tissue repair, and is conducting preclinical studies on a number of cardiovascular applications including an emulsified, injectible form of its ECM Technology as a potential treatment for heart failure.
About CorMatrix Cardiovascular, Inc.
CorMatrix Cardiovascular, a privately held company based in Atlanta, Georgia, is dedicated to developing and delivering innovative biomaterial devices that harness the body's own innate ability to regenerate damaged heart tissue. For more information visit http://www.cormatrix.com.
'/>"/>
| SOURCE CorMatrix Cardiovascular Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Aposense Receives Frost & Sullivan Technology Innovation of the Year Award
2. Frost & Sullivan Awards Genpathway 2008 Healthcare Innovation Award
3. Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
4. Frost & Sullivan Acknowledges ISTO Technologies Role in Developing Advanced Biologic Products for Bone Healing
5. Small Animal Imaging Market: Biospace Lab Wins Frost & Sullivan Accolade for Its Successful Product Line Strategy
6. Celsis Receives Frost & Sullivan 2008 Best Practices Award
7. ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems
8. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
9. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
10. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
11. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
Post Your Comments:
Breaking Biology Technology:Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4Oxford BioTherapeutics Appoints Michael Moore as Chairman 2Oxford BioTherapeutics Appoints Michael Moore as Chairman 3Oxford BioTherapeutics Appoints Michael Moore as Chairman 4Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 2Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 3
[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics[0] Oxford BioTherapeutics Appoints Michael Moore as Chairman[0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas[0] Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors
Other Biology Technology:GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy 2Physicians Expect to Shift More Time to Online Professional Resources in the Coming Years 2Physicians Expect to Shift More Time to Online Professional Resources in the Coming Years 3PAREXEL Closes the Acquisition of ClinPhone 2PAREXEL Closes the Acquisition of ClinPhone 3PAREXEL Closes the Acquisition of ClinPhone 4PAREXEL Closes the Acquisition of ClinPhone 5
Breaking Biology News(10 mins):Study reveals how Arctic food webs affect mercury in polar bears 2Why King Kong failed to impress 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 1New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 6Xanodyne Announces Appointment of Mr Vaughn M Kailian of MPM Capital to the Board of Directors 48789 1Xanodyne Announces Appointment of Mr Vaughn M Kailian of MPM Capital to the Board of Directors 48789 2Dual role in breast tissue for a protein involved in leukemia 8815 1Dual role in breast tissue for a protein involved in leukemia 8815 2
Other Biology News:New book suggests Earth perhaps not such a benevolent mother after all 2New book suggests Earth perhaps not such a benevolent mother after all 3URI receives $18 million grant to strengthen biomedical research capacity in Rhode Island 2URI receives $18 million grant to strengthen biomedical research capacity in Rhode Island 3URI receives $18 million grant to strengthen biomedical research capacity in Rhode Island 4Early identification of dementia increasingly difficult 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |